Janney Capital Management LLC Ligand Pharmaceuticals Inc Transaction History
Janney Capital Management LLC
- $1.55 Billion
- Q2 2025
A detailed history of Janney Capital Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Janney Capital Management LLC holds 3,689 shares of LGND stock, worth $563,273. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,689
Previous 4,169
11.51%
Holding current value
$563,273
Previous $438,000
4.34%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding LGND
# of Institutions
292Shares Held
18.9MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$319 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$162 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$141 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$114 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.58B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...